publication . Article . 2011

Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy

Savina Nodari; Marco Triggiani; Umberto Campia; Alessandra Manerba; G Milesi; Bruno Mario Cesana; Mihai Gheorghiade; Livio Dei Cas;
Open Access
  • Published: 01 Jan 2011 Journal: Journal of the American College of Cardiology, volume 57, issue 7, pages 870-879 (issn: 0735-1097, Copyright policy)
  • Publisher: Elsevier BV
ObjectivesThis study was designed to test the effects of n-3 polyunsaturated fatty acids (PUFAs) on left ventricular (LV) systolic function in chronic heart failure (HF) due to nonischemic dilated cardiomyopathy (NICM).BackgroundOne hundred thirty-three patients with NICM and minimal symptoms on standard therapy were randomized to 2 g of n-3 PUFAs or placebo. LV function and functional capacity were assessed prospectively by echocardiography and cardiopulmonary exercise testing at baseline and at 12 months after randomization.MethodsPatients with chronic HF due to NICM and minimal symptoms while receiving evidence-based therapy were enrolled. LV function and fun...
free text keywords: Cardiology and Cardiovascular Medicine, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701, cardiomyopathy, functional capacity, heart failure, nonischemic myocardial function, n-3 PUFAs, NYHA functional class, Dilated cardiomyopathy, medicine.disease, medicine, In patient, Polyunsaturated fatty acid, chemistry.chemical_classification, chemistry, business.industry, business, Cardiology, medicine.medical_specialty, Ventricular function, Internal medicine, Heart failure, Cardiomyopathy, Randomization, Placebo
22 references, page 1 of 2

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:e46 - e215.

2. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223-30.

3. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000;102:1264 -9.

4. Grimsgaard S, Bonaa KH, Hansen JB, Myhre ES. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 1998;68:52-9.

5. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulindependent diabetes mellitus. Arterioscler Thromb 1994;14:1425-9.

6. Duda MK, O'Shea KM, Tintinu A, et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 2009;81:319 -27.

7. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18: 1440 - 63.

8. Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 2007;50:381-96. [OpenAIRE]

9. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. Philadelphia, PA: Lea and Febiger, 1987.

10. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60: 2020 -7. [OpenAIRE]

11. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010;122:191-225.

12. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479 - 86.

13. Marangoni F, Colombo C, Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem 2004;326:267-72.

14. Vargiu R, Littarru GP, Fraschini M, et al. Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle. Biofactors 2010;36:229 -39. [OpenAIRE]

15. Vargiu R, Littarru GP, Faa G, Mancinelli R. Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters. Biofactors 2008;32:135- 44.

22 references, page 1 of 2
Any information missing or wrong?Report an Issue